BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 26776090)

  • 21. SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson's disease.
    Emelyanov A; Kulabukhova D; Garaeva L; Senkevich K; Verbitskaya E; Nikolaev M; Andoskin P; Kopytova A; Milyukhina I; Yakimovskii A; Timofeeva A; Prakhova L; Ilves A; Vlasova I; Pchelina S
    J Neurol Sci; 2018 Dec; 395():135-140. PubMed ID: 30316070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common variants in PARK loci and related genes and Parkinson's disease.
    Chung SJ; Armasu SM; Biernacka JM; Lesnick TG; Rider DN; Lincoln SJ; Ortolaza AI; Farrer MJ; Cunningham JM; Rocca WA; Maraganore DM
    Mov Disord; 2011 Feb; 26(2):280-8. PubMed ID: 21412835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-synuclein gene polymorphism affects risk of dementia in Han Chinese with Parkinson's disease.
    Zheng J; Zang Q; Hu F; Wei H; Ma J; Xu Y
    Neurosci Lett; 2019 Jul; 706():146-150. PubMed ID: 31102707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of tau gene polymorphism with age at onset of Parkinson's disease.
    Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
    Neurosci Lett; 2006 Sep; 405(3):202-6. PubMed ID: 16876320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between alpha-synuclein (SNCA) rs11931074 variability and susceptibility to Parkinson's disease: an updated meta-analysis of 41,811 patients.
    Du B; Xue Q; Liang C; Fan C; Liang M; Zhang Y; Bi X; Hou L
    Neurol Sci; 2020 Feb; 41(2):271-280. PubMed ID: 31758346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The analysis of association between SNCA, HUSEYO and CSMD1 gene variants and Parkinson's disease in Iranian population.
    Shahmohammadibeni N; Rahimi-Aliabadi S; Jamshidi J; Emamalizadeh B; Shahmohammadibeni HA; Zare Bidoki A; Akhavan-Niaki H; Eftekhari H; Abdollahi S; Shekari Khaniani M; Shahmohammadibeni M; Fazeli A; Motallebi M; Taghavi S; Ahmadifard A; Shafiei Zarneh AE; Andarva M; Dadkhah T; Khademi E; Alehabib E; Rahimi M; Tafakhori A; Atakhorrami M; Darvish H
    Neurol Sci; 2016 May; 37(5):731-6. PubMed ID: 26732583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr Stage.
    Shi C; Zheng Z; Wang Q; Wang C; Zhang D; Zhang M; Chan P; Wang X
    PLoS One; 2016; 11(6):e0155758. PubMed ID: 27299523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease.
    Goris A; Williams-Gray CH; Clark GR; Foltynie T; Lewis SJ; Brown J; Ban M; Spillantini MG; Compston A; Burn DJ; Chinnery PF; Barker RA; Sawcer SJ
    Ann Neurol; 2007 Aug; 62(2):145-53. PubMed ID: 17683088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of SNCA variants with α-synuclein of gastric and colonic mucosa in Parkinson's disease.
    Chung SJ; König IR; Lohmann K; Hinrichs F; Kim J; Ryu HS; Lee HJ; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Hong SM; Myung SJ; Klein C
    Parkinsonism Relat Disord; 2019 Apr; 61():151-155. PubMed ID: 30424941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association analysis of the GRN  rs5848 and MAPT rs242557 polymorphisms in Parkinson's disease and multiple system atrophy: a large-scale population-based study and meta-analysis.
    Chen Y; Cao B; Ou R; Chen X; Zhao B; Wei Q; Wu Y; Shang HF
    Int J Neurosci; 2016 Oct; 126(10):947-54. PubMed ID: 26303052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease.
    Paul KC; Schulz J; Bronstein JM; Lill CM; Ritz BR
    JAMA Neurol; 2018 Mar; 75(3):360-366. PubMed ID: 29340614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SNP rs7684318 of the alpha-synuclein gene is associated with Parkinson's disease in the Han Chinese population.
    Yu L; Xu P; He X; Hu F; Lin Z; Zhu M; Liu Z; He L; Xu Y
    Brain Res; 2010 Jul; 1346():262-5. PubMed ID: 20513365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorder.
    Toffoli M; Dreussi E; Cecchin E; Valente M; Sanvilli N; Montico M; Gagno S; Garziera M; Polano M; Savarese M; Calandra-Buonaura G; Placidi F; Terzaghi M; Toffoli G; Gigli GL
    Neurol Sci; 2017 Jul; 38(7):1233-1240. PubMed ID: 28409245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-synuclein (SNCA) polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.
    Han W; Liu Y; Mi Y; Zhao J; Liu D; Tian Q
    Am J Med Genet B Neuropsychiatr Genet; 2015 Mar; 168B(2):123-34. PubMed ID: 25656566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.
    Wider C; Ross OA; Nishioka K; Heckman MG; Vilariño-Güell C; Jasinska-Myga B; Erketin-Taner N; Rademakers R; Graff-Radford NR; Mash DC; Papapetropoulos S; Duara R; Uchikado H; Wszolek ZK; Farrer MJ; Dickson DW
    J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):424-9. PubMed ID: 22291217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.
    Paul KC; Rausch R; Creek MM; Sinsheimer JS; Bronstein JM; Bordelon Y; Ritz B
    J Parkinsons Dis; 2016 Apr; 6(2):349-59. PubMed ID: 27061069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SNCA: major genetic modifier of age at onset of Parkinson's disease.
    Brockmann K; Schulte C; Hauser AK; Lichtner P; Huber H; Maetzler W; Berg D; Gasser T
    Mov Disord; 2013 Aug; 28(9):1217-21. PubMed ID: 23674386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An updated analysis with 45,078 subjects confirms the association between SNCA rs11931074 and Parkinson's disease.
    Liu X; Zhu R; Xiao T; Li Q; Zhu Y; He Z
    Neurol Sci; 2018 Dec; 39(12):2061-2069. PubMed ID: 30120622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [SNCA rs356219 AND rs356165 VARIANTS ARE ASSOCIATED WITH PARKINSON'S DISEASE AND INCREASED ALPHA-SYNUCLEIN GENE EXPRESSION IN THE CD45(+)-BLOOD CELLS].
    Emelyanov AK; Andoskin PA; Miliukhina IV; Timofeeva AA; Yakimovskii AF; Senkevich KA; Nikolaev MA; Pchelina SN
    Tsitologiia; 2016; 58(2):99-104. PubMed ID: 27228655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of alpha-synuclein and tau genotypes in Parkinson's disease.
    Mamah CE; Lesnick TG; Lincoln SJ; Strain KJ; de Andrade M; Bower JH; Ahlskog JE; Rocca WA; Farrer MJ; Maraganore DM
    Ann Neurol; 2005 Mar; 57(3):439-43. PubMed ID: 15732111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.